ROSSI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 888
EU - Europa 513
AS - Asia 183
SA - Sud America 31
AF - Africa 14
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.634
Nazione #
US - Stati Uniti d'America 867
IT - Italia 209
CN - Cina 58
FR - Francia 56
GB - Regno Unito 52
CH - Svizzera 36
DE - Germania 35
VN - Vietnam 31
IN - India 30
ES - Italia 27
NL - Olanda 20
CA - Canada 17
JP - Giappone 14
HK - Hong Kong 12
PL - Polonia 12
AR - Argentina 10
BR - Brasile 10
TW - Taiwan 10
BE - Belgio 7
RO - Romania 7
RU - Federazione Russa 7
ZA - Sudafrica 7
GR - Grecia 6
CO - Colombia 5
DK - Danimarca 5
FI - Finlandia 5
KR - Corea 5
SE - Svezia 5
TN - Tunisia 5
TR - Turchia 5
AU - Australia 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CZ - Repubblica Ceca 3
LT - Lituania 3
MT - Malta 3
PE - Perù 3
QA - Qatar 3
BD - Bangladesh 2
CR - Costa Rica 2
EG - Egitto 2
IE - Irlanda 2
IR - Iran 2
LU - Lussemburgo 2
MX - Messico 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
AP - ???statistics.table.value.countryCode.AP??? 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
IL - Israele 1
KZ - Kazakistan 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.634
Città #
Fairfield 109
Ashburn 64
Santa Cruz 64
Houston 62
Woodbridge 40
Seattle 37
Ann Arbor 36
Torino 36
Cambridge 34
Buffalo 31
Wilmington 31
Dong Ket 23
Los Angeles 18
Zurich 17
Turin 16
Shanghai 15
Milan 13
Vicopisano 12
Chicago 10
Beijing 9
Bengaluru 8
Boardman 8
Clearwater 8
Columbus 8
Las Vegas 8
Pisa 8
San Diego 8
Taipei 8
Warsaw 8
Amsterdam 7
Delhi 7
University Park 7
Athens 6
Berlin 6
Córdoba 6
Florence 6
Muizenberg 6
New York 6
Rome 6
Wohlen 6
London 5
Munro 5
Pavia 5
Chatsworth 4
Lake Forest 4
Leiden 4
Lexington 4
Madrid 4
Mesa 4
Mountain View 4
Ottawa 4
Philadelphia 4
Provo 4
Sheffield 4
Ankara 3
Barcelona 3
Bernaville 3
Bogotá 3
Boston 3
Burgdorf 3
Charlestown 3
Chennai 3
Council Bluffs 3
Dallas 3
Des Moines 3
Edmond 3
Fremont 3
Guangzhou 3
Haikou 3
Helsinki 3
Herndon 3
Ho Chi Minh City 3
Holbeek 3
Madison 3
Milpitas 3
Milwaukee 3
Montreal 3
Parma 3
Perth 3
Reston 3
Rotterdam 3
San Jose 3
Southend 3
Swindon 3
Tokyo 3
Zhengzhou 3
Ahmedabad 2
Atlanta 2
Bassano del Grappa 2
Bicester 2
Brent 2
Brookline 2
Buenos Aires 2
Cairo 2
Changsha 2
Chengdu 2
Cheyenne 2
Cluj-Napoca 2
Cluj-napoca 2
Copenhagen 2
Totale 1.001
Nome #
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology, file e27ce42a-bfb8-2581-e053-d805fe0acbaa 331
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab, file e27ce42d-a247-2581-e053-d805fe0acbaa 227
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring, file e27ce42e-d349-2581-e053-d805fe0acbaa 225
A role for GDNF and soluble APP as biomarkers of amyotrophic lateral sclerosis pathophysiology, file e27ce42f-1ee2-2581-e053-d805fe0acbaa 107
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study, file e27ce42d-eeb6-2581-e053-d805fe0acbaa 98
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience, file e27ce430-e2fe-2581-e053-d805fe0acbaa 96
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents, file e27ce42d-cded-2581-e053-d805fe0acbaa 95
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond, file e27ce42f-de50-2581-e053-d805fe0acbaa 95
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study, file e27ce42f-c97d-2581-e053-d805fe0acbaa 88
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis, file e27ce432-7c6f-2581-e053-d805fe0acbaa 75
A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response, file e27ce432-45e4-2581-e053-d805fe0acbaa 47
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients, file 78634fc4-f863-42cb-941c-b51d282574eb 36
Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab, file e27ce435-723e-2581-e053-d805fe0acbaa 35
Renal Fibrosis in Lupus Nephritis, file 9828c83a-6f2f-455a-b6be-745d6b61e0bb 30
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation, file e27ce430-9b3b-2581-e053-d805fe0acbaa 30
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy, file e27ce435-3949-2581-e053-d805fe0acbaa 26
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions, file 73cdcf9e-20e1-4169-887a-02a6ac1fb4a5 8
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort, file e27ce42d-ec86-2581-e053-d805fe0acbaa 6
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience, file f2f69fe9-88f1-483b-bab2-50108e2ff0ba 5
Daratumumab monotherapy for refractory lupus nephritis, file 012fba5e-09fa-4702-97eb-176cd745d5c9 4
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients, file e27ce42f-b109-2581-e053-d805fe0acbaa 4
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19, file e27ce42f-fe97-2581-e053-d805fe0acbaa 4
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation, file e27ce430-9b3a-2581-e053-d805fe0acbaa 3
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients, file e27ce432-3a47-2581-e053-d805fe0acbaa 3
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App, file 8652c547-b14b-4867-8748-cbeae989f13d 2
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol, file bbc707de-c8d7-46d2-8baf-665234b527a0 2
Nailfold Capillaroscopy Patterns, file e27ce42e-cf08-2581-e053-d805fe0acbaa 2
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis, file e27ce430-d55b-2581-e053-d805fe0acbaa 2
Pregnancy outcomes in Behçet's disease: Results from a monocentric cohort, file c742fb2a-35f3-4c38-b1ab-226de4f285ea 1
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab, file e27ce42d-bd6e-2581-e053-d805fe0acbaa 1
Totale 1.688
Categoria #
all - tutte 3.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 14 14
2019/2020203 6 8 6 17 13 7 17 25 36 19 36 13
2020/2021326 20 26 16 16 40 35 20 25 29 32 29 38
2021/2022418 46 28 30 48 43 18 29 15 21 29 82 29
2022/2023379 10 16 83 69 22 35 19 14 40 20 36 15
2023/2024231 12 17 31 18 35 8 32 34 14 18 12 0
Totale 1.688